Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare, aggressive hematologic malignancy classified by WHO and marked by cutaneous lesions, bone marrow infiltration, and CNS involvement.

Cell C to be worth as much as R12bn on listing By Nicola Mawson, Contributing journalistJohannesburg, 13 Nov 2025Blu Label Unlimited, through The Prepaid Company, will continue to hold a share of Cell ...

Researchers at University of Tsukuba have achieved high-resolution visualization of cellular organelles, such as nuclei and ...

Shares in Agios Pharma lost nearly half their value in pre-market trading today after it posted mixed clinical results from a ...

An AI tool that can analyze abnormalities in the shape and form of blood cells, and with greater accuracy and reliability ...

A small label installed on a wire when a giant cargo ship was built may have triggered a chain of events nearly a decade ...

Trial met primary endpoint of hemoglobin response and key secondary endpoints of change from baseline in hemoglobin concentration and indirect ...

CELL C HOLDINGS LIMITED ANNOUNCES ITS INTENTION TO LIST ON THE MAIN BOARD OF THE JSE • Cell C Limited (‘Cell C’) is a South African telecommunications and technology company, with a recognisable brand ...

Cell C listing to result in R2.4bn BEE deal By Nicola Mawson, Contributing journalistJohannesburg, 05 Nov 2025Cell C CEO Jorge Mendes. (Photograph by Nicola Mawson) Blu Label Unlimited, formerly Blue ...

One small compartment inside the nucleus has come into focus with regards to aging: the nucleolus. Its main job is simple and ...

South African mobile operator Cell C and The Prepaid Company (TPC) are targeting gross proceeds of up to 6.5 billion rand ($375 million) from the sale of shares ahead of Cell C's planned listing on ...

The treatment landscape for systemic lupus erythematosus (SLE) has shifted greatly in recent years, driven by the emergence ...